AxoGen was honored to ring the opening bell at Nasdaq on Tuesday, November 21, 2017. President and CEO Karen Zaderej, surrounded by members of the AxoGen team, officially opened trading at 9:30 a.m.

The Company was in New York City to host our Second Annual Analyst and Investor Day, where we announced the expansion of our platform for nerve repair to now include breast reconstruction neurotization following mastectomy. We also provided an update and overview of our solutions for nerve damage in our current core applications of extremity trauma, nerve compression, and oral and maxillofacial procedures.